Creative Bioarray Designs Comprehensive Tools and Protocols to Construct Animal Disease Models

September 22, 2022

As a world leader in biotechnology products and services, Creative Bioarray is dedicated to delivering an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services. With years of experience, Creative Bioarray focuses on developing unique technologies that provide global scientists with high-quality products and satisfactory services to facilitate the investigation of life science research. Recently, Creative Bioarray announces the release of its comprehensive tools and protocols to help construct animal disease models.


Creative Bioarray has established a variety of animal disease models, including cardiovascular disease models, chronic liver disease models, metabolic disease models, neurological disease models, tumor models, etc. Creative Bioarray provides validated and customized in vivo disease modeling and services. Comprehensive animal disease models based on different organ systems enable customers to select the most appropriate models to test promising compounds and optimize lead candidates.


Creative Bioarray's oncology models are key tools for current and future cancer research. They can study both normal and abnormal gene interactions in tumors and the reproduction of human disease in mice, providing a key resource for chemoprevention research and the development and testing of novel cancer therapies. In addition to the comprehensive oncology models, Creative Bioarray offers comprehensive pharmacology and pharmacodynamics, toxicology, safety assessment, pharmacokinetics and toxicokinetic services.


Creative Bioarray has successfully developed various cardiovascular models to help develop drugs for cardiovascular disease. The use of animal models can help increase researchers' understanding of cardiovascular disease and provide new avenues for improving disease diagnosis and treatment. In addition, these models can be used to screen for adverse drug reactions and help assess cardiotoxicity. Creative Bioarray also offers a variety of CVD models and key technologies to help develop new compounds.


Creative Bioarray provides professional drug testing services using metabolic disease models, and has developed a variety of metabolic disease models to test the efficacy of drugs according to customer needs, with a variety of species to choose from, such as non-human primates, dogs, mice and rats, rabbits and guinea pigs.


Our disease models also include liver disease models, respiratory disease models and ocular disease models etc., said Hannah Cole, the marketing director of Creative Bioarray, she also claimed, “Each of our disease models is designed to understand specific aspects of drug properties and their mechanisms of action, and we are capable to customize a new model to meet your particular needs.


About Creative Bioarray

Creative Bioarray is dedicated to offering customers innovative biotechnology products and services for research use to greatly enhance and drive innovation and standards in science. As a well-recognized industry leader with more than 10 years of experience and in-house expert support, Creative Bioarray has already countenanced research all around the world.